Online
|
|
NSE Announcements on Plethico Pharma
Posted by :
MMB MessengerPlethico Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 29, 2009, titled "Plethico Pharmaceuticals Ltd - Summary of Financial Performance for 1st Quarter 2009 (unaudited)". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). ...
BSE Announcements on Plethico Pharma
Posted by : MMB MessengerPlethico Pharmaceuticals Ltd has informed BSE about the unaudited Stanalone & Consolidated financial results for the Quarter ended March 31, 2009....
BSE Announcements on Plethico Pharma
Posted by : MMB MessengerPlethico Pharmaceuticals Ltd has informed BSE regarding a Press Release dated April 29, 2009 titled "Performance Highlights"....
Book closure for dividend
Posted by : vkk43Plethico Pharmaceuticals Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from June 22, 2009 to June 26, 2009 (both days inclusive) for the purpose of dividend and 16th Annual General Meeting (AGM) of the Company to be held on June 26, 2009....
Plethico Pharma
Posted by :
amresh_1973
Net Sales/Income from Operations 11696.69
Other Operating Income -
Increase/Decrease in Stock in trade and work in progress 80.78
Consumption of Raw Materials 5095.08
Purchase of traded goods 478.08
Employees Cost 773.56
Depreciation 348.10
Other Expenditure 1690.13
Total Expenditure 8465.73
Profit from Operations before Other Income, Interest & Exceptional Items 3230.96
Other Income 23.63
Profit before Interest & Exceptional Items 3254.59
Interest 639.32
Profit after Interest but before Exceptional Items 2615.27
Exceptional items -
Profit(+)/Loss(-) from Ordinary Activities before tax 2615.27
Tax Expense 103.57
Net Profit(+)/Loss(-) from Ordinary Activities after tax 2511.70
Extraordinary Items 6825.00
Net Profit (+) / Loss (-) for the period -4313.30
Dividend (%) 25
Face Value (in Rs.) 10.00
Paid-up Equity Share Capital 3406.67
Reserves excluding Revaluation Reserves -
Basic EPS before Extraordinary items (in Rs.) 7.37
Diluted EPS before Extraordinary items (in Rs.) 7.37
Basic EPS after Extraordinary items (in Rs.) -12.66
Diluted EPS after Extraordinary items (in Rs.) -12.66
Public Shareholding (Number of Shares) 4426667.00
Public Shareholding (%) 12.99...
BSE Announcements on Plethico Pharma
Posted by : MMB MessengerPlethico Pharmaceuticals Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from June 22, 2009 to June 26, 2009 (both days inclusive) for the purpose of dividend and 16th Annual General Meeting (AGM) of the Company to be held on June 26, 2009....
BSE Announcements on Plethico Pharma
Posted by : MMB MessengerPlethico Pharmaceuticals Ltd has submitted to BSE a copy Press Release dated March 31, 2009 titled "Summary of Financial Performance for Quarter IV, 2008 (AUDITED)"....
NSE Announcements on Plethico Pharma
Posted by : MMB MessengerPlethico Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 31, 2009 for the audited financial results of the Company for quarter and accounting year ended on December 31, 2008. A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). ...
dividend
Posted by : vkk43Plethico Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 31, 2009, inter alia, has recommended dividend @ 25% i.e. Rs 2.50 per equity share of the Company....
NSE Announcements on Plethico Pharma
Posted by : MMB MessengerPlethico Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at their meeting held on March 31, 2009 considered the proposals and following decision were taken:- (1) The Board has recommended dividend @ 25 % i.e. Rs. 2.50 per equity share of the Company. (2) The Annual General Meeting of the members of the Company for the accounting year ended on December 31, 2008 is scheduled to be held on June 26, 2009. (3) The Register of Members and Share Transfer Books will remain closed from June 22, 2009 to June 26, 2009 (both days inclusive) for the purpose of distribution of dividend to the members for the accounting year ended on December 31, 2008....
BSE Announcements on Plethico Pharma
Posted by : MMB MessengerPlethico Pharmaceuticals Ltd has informed BSE about the Audited Standalone Financial Results for Quarter & Year ended for December 31, 2008 & Audited Consolidated Financial Results for the Year ended December 31, 2008....
BSE Announcements on Plethico Pharma
Posted by : MMB MessengerPlethico Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 31, 2009, inter alia, has recommended dividend @ 25% i.e. Rs 2.50 per equity share of the Company....
NSE Announcements on Plethico Pharma
Posted by : MMB MessengerPlethico Pharmaceuticals Limited has informed the Exchange that at the Extra-Ordinary General Meeting of the members of the Company held on March 31, 2009, the following decision have been approved by the members of the Company: (1) The issuance of equity shares and/or FCCB and/or GDR and/or other securities convertible into equity shares and/or such other equity-linked instruments to an extent of US$ 40 Million Indian Rupee equivalent. (2) Authority to Board of Directors to borrow in excess of paid-up capital and free reserve to an extent of Rs. 1200 Crores (Rupees One Thousand Two Hundred Crores only) at a time....
BSE Announcements on Plethico Pharma
Posted by : MMB Messenger
Plethico Pharmaceuticals Ltd has informed BSE that the members at the Extra Ordinary General Meeting (EGM) of the Company held on March 31, 2009, have approved the following decision:
1. The issuance of equity shares and/or FCCB and/or GDR and/or other securities convertible into equity shares and/or such other equity-linked instruments to an extent of US$ 40 Million Indian Rupee equivalent.
2. Authority to Board of Directors to borrow in excess of paid-up capital and free reserve to an extent of Rs. 1200 Crores (Rupees One Thousand Two Hundred Crores only) at a time....
plethico a great company
Posted by :
gunnuuplethico pharma is a great company in nutraceuticals segment and very low PE RATIO with high book value it will be a multi bagger stock buy it and hold tight...
